Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
about
Axitinib in the treatment of renal cell carcinoma: patient selection and perspectivesAxitinib in metastatic renal cell carcinoma: beyond the second-line setting.Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma.Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.
P2860
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
@en
type
label
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
@en
prefLabel
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
@en
P2093
P2860
P1433
P1476
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
@en
P2093
Brian I Rini
Jamal Tarazi
Janice P Dutcher
May Garrett
Robert J Motzer
Walter M Stadler
Yazdi K Pithavala
P2860
P2888
P304
P356
10.1007/S11523-015-0389-2
P577
2015-09-24T00:00:00Z